Inflammasome targeting for periodontitis prevention is sex dependent
Open Access
- 27 October 2025
- journal article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 122 (44)
Abstract
Inflammasome initiates inflammation via the maturation of interleukin-1 beta (IL-1β). Periodontitis is a prevalent, male-biased disease characterized by inflammation-driven bone loss, yet the mechanism(s) of this sex bias is unknown. This study explored whether enhanced inflammasome represents a causal mechanism for this bias. Analyses of three separate human studies (>6,200 samples) show that males have significantly higher IL-1β in the gingival crevicular fluid than females during health and periodontitis. This pattern is experimentally reproduced with different versions of the ligature-induced periodontitis mouse model where males show greater IL-1β secretion than females. The inflammasome drives bone resorption in males but not females as revealed by analyses of inflammasome gene-deletion mice. Pharmacologic treatment with a caspase-1/4 inhibitor reduces inflammatory cell infiltration, dampens osteoclastogenesis signaling (via the receptor activator of nuclear factor-kappa B pathway), and prevents bone resorption in males but not females during experimental periodontitis. While ovariectomized females show no change in their nonresponsiveness to caspase-1/4 inhibition, orchiectomized males no longer respond to the inhibition, suggesting the importance of an intact male reproductive system in the mediation of this inhibition. Thus, our study identifies inflammasome activation as causal for male-biased experimental periodontitis and supports sex-stratified studies to foster future advancement of inflammasome therapeutics in periodontics.Keywords
Funding Information
- HHS | NIH | National Institute of Allergy and Infectious Diseases (AI029564)
- HHS | NIH | National Institute of Dental and Craniofacial Research (DE032830)
- HHS | NIH | National Institute of Dental and Craniofacial Research (DE027087)
- HHS | NIH | National Institute of Dental and Craniofacial Research (DE0234804)
- HHS | NIH | National Institute of Dental and Craniofacial Research (DE029625)
- HHS | NIH | National Institute of Dental and Craniofacial Research (DE029200)
- HHS | NIH | National Institute of Allergy and Infectious Diseases (AI153265)
- HHS | NIH | National Institute of Allergy and Infectious Diseases (AI158314)
- HHS | NIH | National Institute of Allergy and Infectious Diseases (AI067798)
- HHS | NIH | NCI | Division of Cancer Prevention, National Cancer Institute (CA232109)
- HHS | NIH | National Center for Advancing Translational Sciences (UL1TR002489)
- HHS | NIH | National Center for Advancing Translational Sciences (UL1TR002489-03S2)
- HHS | NIH | National Heart, Lung, and Blood Institute (HHSN268201700001I)
- HHS | NIH | National Heart, Lung, and Blood Institute (HHSN268201700002I)
- HHS | NIH | National Heart, Lung, and Blood Institute (HHSN268201700003I)
- HHS | NIH | National Heart, Lung, and Blood Institute (HHSN268201700004I)
- HHS | NIH | National Heart, Lung, and Blood Institute (HHSN268201700005I)
This publication has 66 references indexed in Scilit:
- A randomized, double‐blind phase 1b study evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of the NLRP3 inhibitor selnoflast in patients with moderate to severe active ulcerative colitisClinical and Translational Medicine, 2023
- Investigation of osteoclast cathepsin K activity in osteoclastogenesis and bone loss using a set of chemical reagentsCell Chemical Biology, 2023
- Interferon activated gene 204 protects against bone loss in experimental periodontitisJournal of Periodontology, 2022
- Human oral mucosa cell atlas reveals a stromal-neutrophil axis regulating tissue immunityCell, 2021
- Integrated analysis of multimodal single-cell dataCell, 2021
- RANKL-independent osteoclastogenesis in the SH3BP2 cherubism miceBone Reports, 2020
- Biologically Defined or Biologically Informed Traits Are More Heritable Than Clinically Defined Ones: The Case of Oral and Dental Phenotypes2019
- Induction of Bone Loss by Pathobiont-Mediated Nod1 Signaling in the Oral CavityCell Host & Microbe, 2013
- Functions of RANKL/RANK/OPG in bone modeling and remodelingArchives of Biochemistry and Biophysics, 2008
- Osteoclast stimulatory transmembrane protein (OC‐STAMP), a novel protein induced by RANKL that promotes osteoclast differentiationJournal of Cellular Physiology, 2007